Cibus
Pioneering technologies to precisely target and direct a plant’s own natural gene-editing processes—advancing and accelerating the same breeding techniques farmers have relied on for generations.
Profile
- Industry
- Seeds & genetics
- Topics
- GM traits & gene editing
- Role
- Research / RTO — “…ude Interoc, Fedearroz, and CIAT. <details><summary>Profile sources</summary> - - - - - — 2026-06-30 - - —…”
- Why it is bioeconomy
- Cibus is an agricultural biotechnology company that develops and licenses gene-edited plant traits to seed companies to improve crop productivity and sustainability.
Bio-solutions it supplies 0
Not yet cited as a supplier in a graded solution.
What they offer
This company does not publish its products or services — we find out through an introduction.
Status
- 2026-09 Latest status: Cibus, Inc. entered into a partnership agreement with Crystal Crop Protection Limited to develop gene-edited traits in mustard on September 28, 2026. ↗ ↗ ↗
Recent news 5
Found by automated search; summaries are machine-written in English. The headline names the company or the summary is about it — check the source before relying on it.
- 2026-08-16 Cibus Q2 Earnings Call Highlights - The Lincolnian Online thelincolnianonline.comCibus posted a Q2 2026 revenue of $1.0M (up from $0.9M) with six-month revenue of $2.7M (up 35%), narrowed Q2 net loss to $22.1M, and a leadership focus on near-term revenue, cost discipline, and balance-sheet strength under new CEO Craig Wichner. The company reaffirmed progress …
- 2026-08-13 CBUS - Cibus, Inc. | News | OTC Markets otcmarkets.comCibus is a technology company that uses its proprietary genome-editing platform to improve seed varieties with precise changes to the plant’s own genes (no foreign DNA), licenses those improvements back to seed companies for royalties, and reports a Q2 2026 financial results …
- 2026-08-13 Cibus Reports Second Quarter Financial Results and Provides Business Update | Markets Insider markets.businessinsider.comCibus is a biology-based tech company that develops precise, non-GMO edits to crop genes, licenses the resulting improvements to seed companies for royalties, and aims to turn its platform into shareholder value through commercial partnerships and expanded biotech traits, with …
- 2026-08-13 Cibus Reports Second Quarter Financial Results and Provides Business Update | FinancialContent financialcontent.comCibus is a Nasdaq-listed biotechnology company that uses a proprietary platform to make precise, foreign-DNA-free edits to existing seed varieties, licenses the resulting improvements back to seed companies for royalties, and aims to scale through platform partnerships and later …
- 2026-05-14 Cibus, Inc. (CBUS) 8-K Earnings Release - May 2026 last10k.comCibus is a gene-editing technology company focused on developing and licensing plant traits to seed companies, with momentum in its Rice herbicide tolerance program aiming for a 2027 LATAM and 2029 U.S. launch, ongoing cost discipline, rising revenue, and a pipeline spanning …
Network: owners, partners, peers
Partners & deals 1
| counterparty | Crystal Crop Protection Limited …Cibus, Inc. entered into a partnership agreement with Crystal Crop Protection Limited to develop gene-edited traits in mustard on September 28, 2026.… |
Similar companies
Pairwise · Verinomics · Genective · Solis Agrosciences · MaxEditas · Meiogenix · Confluence Genetics · Thunder Seed Inc.
Company facts
Registry identifiers
- IRS Employer Identification No.: 27-1967997
Funding
- Latest round: Post ipo equity · 2026-03-01 · US$ 15.0 M
- Total raised: US$ 284.3 M
From automated research (company websites, filings, a commercial company index); not checked by hand. Registry identifiers: confirm in the official registry.
Identity & contacts
Contacts, people and legal identity are available to members.
Sign in as a member